Atossa Therapeutics(ATOS) GlobeNewswire·2025-03-20 13:13Core Viewpoint - Atossa Therapeutics, Inc. will host a conference call and live audio webcast on March 25, 2025, to discuss its corporate and financial results for Q4 and full-year 2024 [1] Group 1: Conference Call Details - The conference call is scheduled for 8:30 a.m. Eastern Time [1] - U.S. callers can dial 1-800-836-8184, while international listeners should dial 1-646-357-8785 to join the call [2] - A replay of the conference call will be available for 30 days on the company's investor relations website [3] Group 2: Company Overview - Atossa Therapeutics is a clinical-stage biopharmaceutical company focused on innovative treatments for breast cancer [4] - The lead product candidate, (Z)-endoxifen, is designed for various breast cancer settings, including metastatic and prevention [4] - The company aims to advance clinical research programs to improve patient outcomes and create shareholder value [4]